Lipocine Inc. (LPCN)
Nasdaq: LPCN · Pharmaceutical Preparations · Salt Lake City, US · filing with the SEC since 2011
Who owns Lipocine Inc.
As filed with the SECHolders of 5% or more
2
Squadron Master Fund LP holds 9.8% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
6
report now, of 13 people on the record since 2013. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Squadron Master Fund LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.0001 per share · 6.2% in May 15, 2026
Ikarian Capital, LLC
SCHEDULE 13G · filed May 15, 2026 · Common Stock, par value $0.0001 per share
What LPCN reports owning in othersstakes of 5% or more, and other ties
Lipocine Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
7purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$500,000bought, in dollars
Open-market trades on Form 4 from Oct 1, 2025 to Oct 1, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 1, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 13 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Higuchi John W. | director | 0 | $0 | 0 | 5 | $400,000 |
| Patel Mahesh V. | Chief Executive Officer | 0 | $0 | 0 | 2 | $100,000 |